Zurn Elkay (ZWS) Q4 2025 earnings review
A Flawless Finish with Fortress Balance Sheet
Zurn Elkay delivered a textbook 'beat and raise' quarter to close FY25. Core sales grew 10% YoY, defying broader industrial sluggishness, while Adjusted EBITDA margins expanded 100 basis points to 25.6%. The real story is the balance sheet: Net Debt Leverage hit a record low of 0.4x. With $317M in annual free cash flow and negligible debt, management has massive firepower for M&A or buybacks. FY26 guidance suggests a return to 'mid-single digit' growth, likely a conservative reset after a double-digit growth spurt.
🐂 Bull Case
With net debt leverage at 0.4x—effectively zero—and record free cash flow, Zurn Elkay is over-capitalized. This signals an imminent major acquisition or accelerated buybacks above the $160M repurchased in FY25.
The Zurn Elkay Business System (ZEBS) continues to squeeze efficiencies. Adjusted EBITDA margins expanded 120bps for the full year to 26.1%, proving the company can drive profit growth faster than sales.
🐻 Bear Case
After posting 10-11% core growth in H2 2025, the FY26 guidance calls for 'mid-single digit' growth. While likely conservative, it represents a deceleration that could disappoint investors expecting double-digit momentum to persist.
While not explicitly quantified in the release, prior quarters flagged residential weakness. If the 'mid-single' guidance assumes a further deterioration here, the non-residential buffer needs to hold strong.
⚖️ Verdict: 🟢🟢
Strong Bullish. ZWS is executing perfectly in a mixed macro environment. Double-digit organic growth combined with a pristine balance sheet (0.4x leverage) makes this a high-quality compounder with significant M&A optionality.
Key Themes
Margin Expansion via Productivity
The Zurn Elkay Business System (ZEBS) is delivering tangible results. Despite volume increases which can strain operations, the company expanded Adjusted EBITDA margins by 100 basis points YoY in Q4 to 25.6% and 120 basis points for the full year to 26.1%. Incremental margins were 36% in Q4, demonstrating high-quality earnings growth.
Supply Chain De-Risking
Management's multi-year strategy to exit China is paying off. In prior calls, they targeted China exposure dropping to 2-3% by end of 2026. This proactively insulates the company from tariff volatility that is currently plaguing the industrial sector. The confident guidance affirms they are price-cost positive despite trade headwinds.
Decelerating Guidance vs Current Trends
The company just delivered two consecutive quarters of double-digit core growth (11% and 10%). However, FY26 guidance is set for 'mid-single digit' growth. This suggests either management is extremely conservative (sandbagging) or they see leading indicators of a slowdown in non-residential construction.
Balance Sheet Optionality
Zurn Elkay ended 2025 with Net Debt Leverage of 0.4x, down from 0.8x a year ago. With $300M+ in cash and record free cash flow, the company is under-leveraged. This creates a 'coiled spring' dynamic where a significant acquisition or massive capital return program is mathematically inevitable to optimize capital structure.
Other KPIs
Accelerating. A record result, up 17% from $272M in FY24. FCF conversion was robust, and this cash generation funded $160M in buybacks and dividends while still de-leveraging the balance sheet.
Down significantly from 0.8x in 24Q4 and 0.6x in 25Q3. The balance sheet is essentially debt-free on a net basis, providing maximum flexibility.
Stable/Strong. Matches the high growth rates seen in Q3 (+11%) and accelerates significantly vs 24Q4 (+4%). Driven by growth in 'nearly all product categories'.
Guidance
Decelerating. A slight step down from the +10% realized in 25Q4 and +11% in 25Q3, but remains historically strong compared to the +5% seen in 25Q1.
Stable. The midpoint (25.75%) is roughly in line with 25Q4 (25.6%) and represents ~35% incremental margin contribution, consistent with their long-term model.
Decelerating. Implies ~4-6% growth, a slowdown from the +8% achieved in FY25. Suggests management expects normalization of demand or tougher comps in H2 26.
Accelerating. Forecasts continued growth (+6% YoY) on top of the record FY25 performance ($317M).
Key Questions
Capital Deployment Strategy
With leverage at 0.4x and record cash flow, you are significantly under-leveraged. Is a major acquisition imminent, or should investors expect a more aggressive return of capital beyond the current dividend/buyback pace?
Guidance Conservatism
You exited Q4 with 10% core growth but are guiding FY26 to 'mid-single digits.' Are you seeing specific leading indicators of demand softening, or is this simply prudence given the macro environment?
Tariff Pass-Through
Given the confidence in margins, are you assuming full price pass-through of any 2026 tariff impacts, or is the supply chain exit from China now sufficient to insulate the P&L entirely?